Wachtel S R, Brooderson R J, White F J
Department of Psychiatry, Wayne State University School of Medicine, Detroit, MI 48207.
Psychopharmacology (Berl). 1992;109(1-2):41-8. doi: 10.1007/BF02245478.
The present report investigated several parametric and pharmacological aspects of the enhanced self-grooming behavior of rats following systemic administration of the selective D1 dopamine (DA) receptor agonist SKF 38393. The amount of time that rats spent grooming themselves was measured continuously for 30 min following drug administration to provide a quantitative measure of the drug-induced behavior. SKF 38393 increased the amount of grooming in a dose-dependent manner (0.5-16 mg/kg, SC). The onset of this effect required at least 5 min and it persisted for at least 60 min. The ability of SKF 38393 to enhance grooming was shared by R-SKF 38393, but not S-SKF 38393, consistent with the affinities of these enantiomers for the D1 DA receptor. Unlike SKF 38393, the peripheral D1 agonist fenoldopam (SKF82526) failed to cause an increased grooming response, suggesting a central site of action for elicitation of this behavior. The SKF 38393-induced increase in grooming was competitively antagonized by the D1 selective antagonist SCH 23390 (0.5 mg/kg, SC). Although the D2 DA receptor-selective antagonist eticlopride reduced SKF 38393-elicited grooming, this antagonism appeared to be of a physiological rather than pharmacological nature. When eticlopride was coadministered with the non-selective (mixed) D1/D2 agonist apomorphine, an increase in grooming behavior similar to that produced by SKF 38393 was observed. Inactivation of D1 and D2 DA receptors produced by pretreatment with the irreversible antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), at a dose which reduces D1 and D2 receptor density by > or = 50% (8.0 mg/kg, IP), reduced SKF 38393-induced grooming by approximately 50%.(ABSTRACT TRUNCATED AT 250 WORDS)
本报告研究了选择性D1多巴胺(DA)受体激动剂SKF 38393全身给药后大鼠自我梳理行为增强的几个参数和药理学方面。给药后连续30分钟测量大鼠自我梳理的时间,以提供药物诱导行为的定量测量。SKF 38393以剂量依赖性方式增加梳理量(0.5 - 16 mg/kg,皮下注射)。这种效应的起效至少需要5分钟,并且持续至少60分钟。R - SKF 38393与SKF 38393一样具有增强梳理的能力,但S - SKF 38393则不然,这与这些对映体对D1 DA受体的亲和力一致。与SKF 38393不同,外周D1激动剂非诺多泮(SKF82526)未能引起梳理反应增加,提示该行为的引发作用位点在中枢。SKF 38393诱导的梳理增加被D1选择性拮抗剂SCH 23390(0.5 mg/kg,皮下注射)竞争性拮抗。虽然D2 DA受体选择性拮抗剂依托必利减少了SKF 38393引发的梳理,但这种拮抗作用似乎是生理性的而非药理学性质的。当依托必利与非选择性(混合)D1/D2激动剂阿扑吗啡共同给药时,观察到梳理行为增加,类似于SKF 38393产生的增加。用不可逆拮抗剂N - 乙氧羰基 - 2 - 乙氧基 - 1,2 - 二氢喹啉(EEDQ)预处理使D1和D2 DA受体失活,剂量为使D1和D2受体密度降低≥50%(8.0 mg/kg,腹腔注射),使SKF 38393诱导的梳理减少约50%。(摘要截短于250字)